title: Severe atazanavir-associated hyperbilirubinemia revealing Canton G6PD deficiency in an Asian HIV-infected patient.
authors.forename: Emilie
authors.initials: E
authors.lastname: Javelle
authors.forename: Manuela
authors.initials: M
authors.lastname: Oliver
authors.forename: Hélène
authors.initials: H
authors.lastname: Savini
authors.forename: Camille
authors.initials: C
authors.lastname: Aubry
authors.forename: Catherine
authors.initials: C
authors.lastname: Badens
authors.forename: Fabrice
authors.initials: F
authors.lastname: Simon
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000009:adverse effects*; D044466:Asian People / Q000235:genetics*; D000069446:Atazanavir Sulfate; D005878:Gilbert Disease / Q000175:diagnosis* / Q000235:genetics; D005955:Glucosephosphate Dehydrogenase Deficiency / Q000175:diagnosis* / Q000235:genetics; D006679:HIV Seropositivity / Q000150:complications* / Q000188:drug therapy / Q000235:genetics; D006801:Humans; D006932:Hyperbilirubinemia / Q000139:chemically induced* / Q000235:genetics; D008297:Male; D009842:Oligopeptides / Q000008:administration & dosage / Q000009:adverse effects*; D011725:Pyridines / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D019380:Anti-HIV Agents; D009842:Oligopeptides; D011725:Pyridines; D000069446:Atazanavir Sulfate